Kolexia
Toussaint-Hacquard Marie
Pharmacien
Hôpital Brabois
Vandoeuvre-lès-Nancy, France
51 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Hémorragie Encéphalopathie ischémique Thrombopénie Thrombose Accident vasculaire cérébral Thromboembolie Défaillance cardiaque Maladie coronarienne Purpura

Industries

Aguettant
4 collaboration(s)
Dernière en 2023
Sanofi
1 collaboration(s)
Dernière en 2022
SARSTEDT FRANCE SARL
1 collaboration(s)
Dernière en 2022
Boehringer Ingelheim
1 collaboration(s)
Dernière en 2020

Dernières activités

Erratum to: Glomerular filtration rate estimated by Cockcroft-Gault formula better predicts anti-Xa levels than Modification of the diet in renal disease equation in older patients with prophylactic enoxaparin.
The journal of nutrition, health & aging   04 janvier 2024
Point-of-care testing for D-dimer in the exclusion of venous thromboembolism: a critical analysis.
Annales de biologie clinique   29 novembre 2023
Factors Influencing anti-Xa assays: A Multicenter Prospective Study in Critically Ill and Noncritically Ill Patients Receiving Unfractionated Heparin.
Thrombosis and haemostasis   15 juin 2023
Smoking and Activated Clotting Time during coronary angiography and angioplasty: protocol for the ACT-Tobacco trial.
Research and practice in thrombosis and haemostasis   14 février 2023
Factors influencing anti-Xa assays in different groups of critically ill and non-critically ill patients receiving unfractionated heparin: A multicenter prospective study
Abstracts of the ISTH 2022 Congress of the International Society of Thrombosis and Haemostasis, July 9–13, 2022   21 octobre 2022
POCT-management during the first wave of Covid-19 in France. Results of a national survey leaded by the SFBC-POCT Working Group.
Annales de biologie clinique   29 décembre 2021
Running after Activated Clotting Time Values in Patients Receiving Direct Oral Anticoagulants: A Potentially Dangerous Race. Results from a Prospective Study in Atrial Fibrillation Catheter Ablation Procedures.
Journal of clinical medicine   18 septembre 2021
DEXHEP: Evaluation of the Effect of Dextran Sulphate on Anti-Xa Activities Measured in Patients Treated With Unfractionated Heparin in Different Indications-DEXHEP
Essai Clinique (CHU Rennes)   08 février 2021
Impact of Geographic Region on the COMMANDER-HF Trial.
JACC. Heart failure   03 février 2021
À l'air libre (66) William Dab: «La santé publique en France, c'est l'armée mexicaine!»
Youtube @ Mediapart   01 février 2021